Rituximab subcutaneous in B-cell non-Hodgkin lymphoma: clinical experience in a single center

被引：3

作者：

Sanchez-Gonzalez, Blanca ^{[1
,2
]}

Torres, Elena ^{[1
]}

Ferraro Rosset, Mariana Paola ^{[1
]}

Calafell, Montserrat ^{[1
]}

Gale, Carmen ^{[1
]}

Martinez, Laia ^{[1
]}

Sancho, Esther ^{[1
]}

Garcia, Pilar ^{[1
]}

Gimeno, Eva ^{[1
]}

Garcia-Pallarols, Francesc ^{[1
]}

Salar, Antonio ^{[1
,2
]}

机构：

[1] Hosp del Mar, Hematol, Passeig Maritim 25-29, Barcelona 08003, Spain

[2] Imim, Barcelona, Spain

来源：

LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 04期

关键词：

FOLLICULAR LYMPHOMA; CHEMOTHERAPY; MAINTENANCE; PHASE-3;

D O I：

10.1080/10428194.2017.1349906

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1019 / 1021

页数：3

共 15 条

[1]

[Anonymous], 2016, MABTHERA

[2]

[Anonymous], 2015, MABTHERA

[3]

[Anonymous], 2009, COMM TERM CRIT ADV E

[4] A recombinant human enzyme for enhanced interstitial transport of therapeutics [J].

Bookbinder, L. H. ;

Hofer, A. ;

Haller, M. F. ;

Zepeda, M. L. ;

G.-A., Keller ;

Lim, J. E. ;

Edgington, T. S. ;

Shepard, H. M. ;

Patton, J. S. ;

Frost, G. I. .

JOURNAL OF CONTROLLED RELEASE, 2006, 114 (02) :230-241

[5]

Boross P, 2012, AM J CANCER RES, V2, P676

[6] Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study [J].

Davies, Andrew ;

Merli, Francesco ;

Mihaljevic, Biljana ;

Siritanaratkul, Noppadol ;

Solal-Celigny, Phillippe ;

Barrett, Martin ;

Berge, Claude ;

Bittner, Beate ;

Boehnke, Axel ;

McIntyre, Christine ;

MacDonald, David .

LANCET ONCOLOGY, 2014, 15 (03) :343-352

[7] Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries [J].

De Cock, Erwin ;

Kritikou, Persefoni ;

Sandoval, Mariana ;

Tao, Sunning ;

Wiesner, Christof ;

Carella, Angelo Michele ;

Ngoh, Charles ;

Waterboer, Tim .

PLOS ONE, 2016, 11 (06)

[8] How we manage follicular lymphoma [J].

Hiddemann, W. ;

Cheson, B. D. .

LEUKEMIA, 2014, 28 (07) :1388-1395

[9] Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study [J].

Pivot, Xavier ;

Gligorov, Joseph ;

Mueller, Volkmar ;

Barrett-Lee, Peter ;

Verma, Sunil ;

Knoop, Ann ;

Curigliano, Giuseppe ;

Semiglazov, Vladimir ;

Lopez-Vivanco, Guillermo ;

Jenkins, Valerie ;

Scotto, Nana ;

Osborne, Stuart ;

Fallowfield, Lesley .

LANCET ONCOLOGY, 2013, 14 (10) :962-970

[10] Diffuse large B-cell lymphoma-treatment approaches in the molecular era [J].

Roschewski, Mark ;

Staudt, Louis M. ;

Wilson, Wyndham H. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (01) :12-23

← 1 2 →